The CBP histone acetyltransferase plays important roles in development and disease by acting as a transcriptional coregulator. A small reduction in the amount of Drosophila CBP (dCBP) leads to a specific loss of signaling by the TGF-␤ molecules Dpp and Screw in the early embryo. We show that the expression of Screw itself, and that of two regulators of Dpp/Screw activity, Twisted-gastrulation and the Tolloid protease, is compromised in dCBP mutant embryos. This prevents Dpp/Screw from initiating a signal transduction event in the receiving cell. Smad proteins, the intracellular transducers of the signal, fail to become activated by phosphorylation in dCBP mutants, leading to diminished Dpp/Screw-target gene expression. At a slightly later stage of development, Dpp/Screw-signaling recovers in dCBP mutants, but without a restoration of Dpp/Screw-target gene expression. In this situation, dCBP acts downstream of Smad protein phosphorylation, presumably via direct interactions with the Drosophila Smad protein Mad. It appears that a major function of dCBP in the embryo is to regulate upstream components of the Dpp/Screw pathway by Smad-independent mechanisms, as well as acting as a Smad coactivator on downstream target genes. These results highlight the exceptional sensitivity of components in the TGF-␤ signaling pathway to a decline in CBP concentration.
Introduction
Transcriptional coregulators have recently been found to contribute important roles to transcription factor function, and thereby to play decisive roles in cell-differentiation during development (reviewed by Mannervik et al., 1999) . Coregulators are recruited to cis-regulatory regions through interactions with DNA-binding proteins. The coactivator CBP (CREBbinding protein) is equipped with intrinsic histone acetyltransferase (HAT) activity and directly interacts with sequencespecific DNA-binding proteins to mediate their transactivation capability through histone acetylation and/or interaction with a RNA polymerase complex (reviewed in Chan and La Thangue, 2001 ). In addition, CBP has the ability to acetylate nonhistone proteins, such as the p53 tumor suppressor and some of the basal transcription factors. The central position of CBP in transcriptional regulation is reflected by its important roles in development and disease (reviewed in Goodman and Smolik, 2000) . Although CBP has been shown to interact with a plethora of mammalian transcription factors, including CREB, nuclear hormone receptors, and Smad proteins, in vivo evidence that supports the biological significance of these interactions is scarce. The Drosophila embryo constitutes an excellent model for making connections between abnormal development and changes in gene expression. We have taken a genetic approach to identify which transcription factor-CBP interactions are important in vivo, using the early Drosophila embryo.
Mutations in the Drosophila CBP ortholog, nejire (nej or dCBP), cause multiple developmental defects, including impairment of Hedgehog and Wingless signaling, as well as defects in dorsal-ventral patterning (Goodman and Smolik, 2000) . In dorsal-ventral patterning, dCBP has been suggested to act as a coactivator for both the Dorsal transcription factor, and for the Smad protein Mad, which transduces the TGF-␤ signal Decapentaplegic (Dpp) (Akimaru et al., 1997b; Waltzer and Bienz, 1999) . Dorsal initiates dorsal-ventral patterning by forming a concentration gradient in the ventral half of the embryo, where it can act as an activator or repressor, depending on DNA context (reviewed in Mannervik et al., 1999) . One gene that is repressed by Dorsal encodes the TGF-␤ signaling molecule Dpp (Huang et al., 1993) . Dpp protein production is in this way confined to the dorsal part of the embryo, from where it is secreted and diffuses toward the ventral side to form an activity gradient that subdivides the dorsal ectoderm (reviewed in Podos and Ferguson, 1999) . This gradient is formed with the help of several other extracellular proteins. An inhibitor of Dpp activity, Short gastrulation (Sog), is produced in lateral parts of the embryo where it is believed to act as a sink for the Dpp protein (Francois et al., 1994) . Interestingly, the Sog protein acts as an inhibitor in lateral cells, but is able to potentiate the Dpp signal far away from its source of synthesis, resulting in peak Dpp activity in dorsal-most cells (Ashe and Levine, 1999) . Twisted gastrulation (Tsg) collaborates with Sog protein in antagonizing Dpp activity (Chang et al., 2001; Ross et al., 2001; Scott et al., 2001) . It is believed that Tsg makes Sog a better substrate for the Tolloid protease, which cleaves the Sog inhibitor to activate the Dpp ligand (Marques et al., 1997) . Differentiation of dorsal-most cells also requires another TGF-␤ molecule, Screw (Arora et al., 1994) . Dpp and Screw proteins bind to serine/threonine kinase receptors (Thick-veins, Saxophone, and Punt), which leads to phosphorylation of the intracellular transducer of the signal, the Smad protein Mad (reviewed in Podos and Ferguson, 1999) . Upon phosphorylation, Mad heterodimerizes with another Smad protein, Medea, and translocates to the nucleus where it binds to DNA and activates Dpp target genes (reviewed in Raftery and Sutherland, 1999) .
In the early Drosophila embryo, dCBP mRNA is maternally contributed. Removal of dCBP from the embryo therefore requires creation of chimeric flies with clones of homozygous germ cells. Oocyte development is blocked in germ cells homozygous for the strong dCBP allele nej 3 (Akimaru et al., 1997a) . However, in the hypomorphic nej 1 allele, homozygous eggs and embryos are produced, but the reduction in dCBP levels results in patterning defects (Akimaru et al., 1997b) . It has previously been observed that expression of Dpp/Screwtarget genes is compromised in dCBP mutant germline clone embryos, leading to the hypothesis that dCBP acts as a Mad Fig. 1 . Expression of dCBP in dCBP mutant embryos. dCBP mRNA and protein expression levels were determined in wild-type (wt) and dCBP mutant (nej 1 ) embryos derived from nej 1 germline clones. Embryos are oriented with anterior to the left and dorsal up. (A, B) Cellularizing wt and mutant (nej 1 ) embryos were hybridized with a digoxigenin-labeled antisense dCBP RNA probe. dCBP mRNA is present ubiquitously due to its maternal contribution. Slightly diminished dCBP mRNA amounts is found in mutant (B) compared with wt (A) embryos. (C-E) Cellularized wt embryos were stained with an antibody directed against the N terminus of the dCBP protein. Staining is predominantly nuclear. In (C), the antibody was left untreated, whereas in (D), it was preincubated with a GST-dCBP fusion protein, resulting in almost complete absence of staining. By contrast, when the antibody was preincubated with GST protein (E), no reduction in staining intensity occurred. (F, G) Transgenic embryos overexpressing dCBP in central parts by use of the Krüppel enhancer (Kr-CBP), stained with the dCBP antibody. In a wt background (F), strong nuclear staining is observed in all cells, which is further enhanced in the central Krüppel domain. In CBP mutant embryos (G), a small reduction in nuclear staining was observed, except in the Krüppel domain, where staining remained strong. In fact, dCBP overexpression was more pronounced and detected at an earlier stage in dCBP mutants due to diminished endogenous dCBP levels (not shown). coactivator (Ashe et al., 2000; Waltzer and Bienz, 1999) . Here, we present results that raise the possibility that Dpp/Screwtarget genes instead fail to be expressed in dCBP mutants because Dpp/Screw is unable to signal. We show that expression of two upstream regulators of Dpp/Screw activity, tsg and tolloid, as well as screw itself, is reduced in dCBP mutants. As a result, Mad is not phosphorylated in cells that would normally receive the Dpp/Screw signal. However, we also present evidence suggesting that, at a slightly later stage of development, dCBP acts downstream of Dpp/Screw-signaling as a Mad coactivator.
Materials and methods

Fly strains and germline clones
Three dCBP alleles were used in this study; nejire 1 (nej 1 ) and nej 3 are excision lines derived from a P-element located 347 base pairs upstream of the second exon in the dCBP gene (Akimaru et al., 1997a) . nej 3 deletes 2-3 kb of DNA near the 5Ј end of the gene, and is believed to be a null allele (Akimaru et al., 1997a) , whereas nej 1 is a hypomorph (Akimaru et al., 1997b) . nej Q7 was isolated in an EMS screen for modifiers of Deformed function, and is a stronger allele than nej 3 and therefore considered an antimorph (Florence and McGinnis, 1998) . dCBP mutant embryos derived from germline clones were generated by the FLP-FRT method (Chou and Perrimon, 1996) . nej 1 FRT/FM7c females were crossed to ovoD FRT/Y; hs-FLP males. Progeny from this cross were heatshocked at 37°C for 3 h on days 3, 4, and 5 after egglaying. nej 1 FRT/ovoD FRT females were crossed to wild-type males, to males containing the tolloid-lacZ transgene (kindly provided by C. Rushlow), or to males carrying a FM7 ftz-lacZ marked balancer chromosome, and embryos collected on apple juice plates. OregonR or yw flies were used as wild-type controls.
P-element construction and transformation
The dCBP cDNA was cloned as an AscI fragment into a modified 22FPE vector (Kosman and Small, 1997) in which the two copies of the even-skipped stripe 2 enhancer have been replaced by two copies of the Krüppel enhancer (described in Stathopoulos et al., 2002 , kindly provided by H. Ashe). The enhancer is followed by the even-skipped basal promoter and leader, an FRT-transcription stop signal-FRT sequence, and the AscI site. The construct was injected into yw flies following standard procedures (Rubin and Spradling, 1982) . The resulting transgenic flies were crossed to ␤ 2 -tubulin-FLP-containing males in order to recombine away the transcriptional stop signal and activate expression of dCBP (Kosman and Small, 1997) . Male progeny in whose spermatocytes recombination had occurred were crossed to wild-type or nej 1 germline clone females and embryos collected as described above.
Generation of dCBP antibody
Amino acids 1-174 of dCBP were amplified by PCR and cloned into the pGEX 5X-1 vector to generate a GST-dCBP fusion protein, which was expressed in bacterial BL21 cells and purified on glutathione-sepharose beads. The fusion protein was injected into guinea pigs (performed by Eurogentec, Belgium), and the serum was passed over a GST column to remove GST reactive antibodies.
In situ hybridization and immunohistochemistry
RNA in situ hybridization using digoxigenin-labeled antisense RNA probes was performed as previously described (Jiang et al., 1991; Tautz and Pfeifle, 1989) . Immunohistochemistry was performed essentially as described previously (Manoukian and Krause, 1992) . Embryos were fixed in 4% formaldehyde and devitellinized in methanol. They were then rehydrated and incubated in PBTH buffer (1ϫ PBS, 0.1% Tween 20, 250 g/ml tRNA, and 50 g/ml Heparin) for 1 h. The guinea pig anti-dCBP polyclonal antibody (1:1000 dilution) or a rabbit anti-phospho Smad polyclonal antibody (kindly provided by C.-H. Heldin, 1:2000 dilution) or a goat anti-Mad polyclonal antibody (Santa Cruz Biotechnology, 1:50 dilution) was added and incubated at 4°C overnight. Embryos were washed in PBTH and the primary antibody detected using the Vectastain ABC Elite kit. In Fig. 1D and E, the dCBP antibody was blocked by preincubation with 10 g GST-dCBP or GST protein at a 1:10 dilution in PBTH at room temperature for 3 h, followed by further dilution of the antibody to a final dilution of 1:1000 prior to adding to embryos. For double labeling, embryos were first subject to immunohistochemistry as described above, except that RNase inhibitor was included in the PBTH buffer and then stained with the rhomboid anti-sense RNA probe.
Results
A small reduction of dCBP levels in dCBP mutant germline clone embryos
Patterning defects have previously been observed in germline clone embryos from the nej 1 allele of dCBP (Akimaru et al., 1997b), but the amount of dCBP present in such embryos has not been previously determined. We therefore examined dCBP mRNA and protein expression in dCBP mutant embryos (Fig. 1) . In both wild-type (Fig. 1A ) and dCBP mutant (Fig. 1B) embryos, dCBP mRNA is present ubiquitously due to its maternal contribution. A small, but reproducible, reduction in dCBP mRNA expression was observed. In order to determine whether a similar change in dCBP protein expression occurs in these embryos, an antibody was raised against the N-terminal part of the protein. Fig. 1C shows a wild-type embryo stained with this antibody. Predominantly, nuclear staining was observed. Preincubation of the antibody with a GST-dCBP fusion protein (Fig. 1D ), but not with GST protein (Fig. 1E) , blocked staining of wild-type embryos, indicating that the antibody is specific for dCBP. Embryos overexpressing dCBP in a central domain by control of the Krüppel enhancer were generated and stained with the antibody. Stronger staining was observed in the Krüppel domain than in the rest of the embryo, demonstrating that the antibody recognizes dCBP (Fig. 1F) . When dCBP mutant embryos containing the Krüppel-dCBP transgene were stained with the antibody, a reduction in the amount of endogenous dCBP was found, while expression in the Krüppel domain remained comparable to that found in the wild-type (Fig. 1G ). These results demonstrate that dCBP protein is still present in dCBP mutant embryos, but at a reduced level. The small reduction of dCBP in these embryos allows us to find genes that are especially sensitive to a decline in dCBP amounts, and for whose expression dCBP may be particularly important.
Expression of dpp, sog, and tsg in dCBP mutant embryos
It has previously been shown that expression of Dpptarget genes, such as Race, hindsight, U-shaped, and rhomboid, is diminished in embryos derived from dCBP germline clones (Ashe et al., 2000; Waltzer and Bienz, 1999) . We have investigated what other genes are affected in the early embryo by the reduction in dCBP levels. In particular, we examined dCBP germline clone embryos for the expression of genes involved in generating active Dpp and Screw protein, to see if dCBP is acting directly or indirectly on Dpp/Screw-target genes.
We first examined the expression of dpp itself, the Dpp inhibitor sog, as well as the Sog partner tsg. The dpp gene is expressed in dorsal parts of the embryo. It is activated by an unknown transcription factor and repressed by Dorsal in ventral cells ( Fig. 2A) (Huang et al., 1993) . In dCBP mutant embryos, dpp is expressed in a normal pattern (Fig. 2B) . The sog gene is expressed in two ventrolateral stripes in response to the lowest threshold of Dorsal activity (Fig. 2C) . It is repressed in ventral parts, presumably by the Snail protein. In dCBP mutant embryos, sog is expressed to a normal extent (Fig. 2D) . From these results, we conclude that the unknown activator of dpp expression and the Dorsal protein are unaffected by the reduction in dCBP levels.
Tsg cooperates with Sog protein in antagonizing Dpp signaling (Ross et al., 2001 ). Its expression is restricted to dorsal cells in the middle of the embryo and to an anterior cap (Fig. 2E) (Mason et al., 1994) . Expression of the anterior cap is reduced in dCBP mutant embryos, and the middorsal domain is narrower than in wild-type embryos (Fig.  2F) . This result suggests that one or more transcriptional activators of tsg expression depend on dCBP for their activity. It is possible that reduced tsg expression in dCBP mutants affects the ability of Dpp/Screw to signal. However, unlike dCBP mutant embryos (Ashe et al., 2000 ; see also Fig. 4) , expression of the Dpp/Screw-target gene rhomboid expands in twisted gastrulation mutants (Ross et al., 2001) . Therefore, diminished tsg expression cannot account for the dCBP mutant phenotype.
Tolloid and screw gene expression require dCBP
The Tolloid protease is necessary for generating active Dpp and Screw protein by cleaving the Sog inhibitor. Like dpp, tolloid is expressed on the dorsal side of cellularizing Drosophila embryos (Shimell et al., 1991) (Fig. 3A) . This pattern is driven by a 800-bp enhancer, to which an unknown, presumably ubiquitous, transcriptional activator binds. Binding of the Dorsal protein together with cofactors to this enhancer results in repression in the ventral half of the embryo (Kirov et al., 1994) . As can be seen in Fig. 3B , the early expression pattern of the tolloid gene is almost completely eliminated in embryos derived from dCBP germline clones. Loss of the early tolloid expression pattern in dCBP mutant embryos indicates that the unidentified protein that activates tolloid transcription uses dCBP as a coactivator. Moreover, it suggests that dCBP has a role in the Dpp/Screw pathway that is independent of Smad proteins, since the early tolloid pattern is unaffected by changes in Dpp signaling (data not shown). The result also indicates that dpp and tolloid expression are activated by different proteins, with only the tolloid activator being dependent on dCBP for its activity.
At a slightly later stage of development, during late cellularization/early gastrulation, tolloid expression refines into a different pattern. As shown in the dorsal view of the wild-type embryo in Fig. 3C , tolloid expression becomes restricted to stripes along the anterior-posterior axis, with absence of staining in dorsal-most cells. This repression of tolloid expression along the dorsal midline is due to Dpp/ Screw signaling. In dCBP mutant embryos, tolloid expression partly recovers at this later stage of development, and additionally, fails to be repressed in dorsal midline cells (Fig. 3D) .
The activity of the isolated 800-bp tolloid enhancer coupled to a lacZ reporter gene was examined in dCBP mutant embryos. As shown previously, the tolloid enhancer recapitulates the early tolloid pattern when introduced into wildtype embryos (Kirov et al., 1994) (Fig. 3E) . However, expression of the tolloid-lacZ gene is eliminated in dCBP mutant embryos; demonstrating that dCBP is regulating transcription driven by the tolloid enhancer (Fig. 3F) .
In addition to Dpp, specification of dorsal-most cell fates requires a second TGF-␤ molecule, Screw (Arora et al., 1994) . Although screw is expressed uniformly in the early embryo (Arora et al., 1994) (Fig. 3G) , its activity is restricted to the dorsal side. In dCBP mutant embryos, screw expression is reduced as compared with wild-type embryos (Fig. 3H) . As dorsal cell fate is sensitive to reductions in the levels of Screw protein (Arora et al., 1994) , diminished screw expression may well contribute to a reduction of Dpp/Screw-target gene expression in dCBP mutant embryos. We have also examined the expression of Brinker, a transcriptional repressor involved in Dpp signaling (Affolter et al., 2001) . No deviation from its normal pattern of expression could be detected in dCBP mutant embryos (data not shown).
In summary, our results have established that transcriptional activators regulating expression of the tsg, tolloid, and screw genes depend on dCBP for their full activity. It appears that the tolloid activator is most sensitive to the reduction in dCBP levels. These data raise the possibility that Dpp/Screw signaling is inhibited in dCBP mutants by too little Tolloid and Screw protein.
TGF-␤ signaling is impaired in early dCBP mutant embryos
Reduced tolloid and screw expression might inhibit Dpp/ Screw signaling, which could explain the previously noted lack of downstream target gene expression. To address this issue, we used an antibody that specifically recognizes phosphorylated Smad proteins (Persson et al., 1998) . Since Smads are phosphorylated only in response to signaling by TGF-␤ molecules, this antibody can be used to measure the activity of Dpp/Screw (Tanimoto et al., 2000) . As previously shown, the anti-phospho Smad antibody stains the dorsal-most region of wild-type embryos, where Dpp/Screw signaling occurs (Dorfman and Shilo, 2001; Ross et al., 2001; Rushlow et al., 2001) (Fig. 4A) . In the dCBP mutant embryo shown in Fig. 4B , anti-phospho Smad staining is reduced, except in an anterior patch of cells, indicating that reduced tolloid and screw expression indeed impedes Dpp/ Screw signaling. Drosophila Smad proteins are maternally contributed to the early embryo and consequently present in all cells. We used an anti-Mad antibody to determine the amount of Mad protein in dCBP mutant embryos. We observed a slight reduction in staining intensity in dCBP mutant embryos as compared with wild-type ( Fig. 4E and  F) . However, we do not believe that this small reduction in Mad protein levels can account for the reduced phosphoSmad staining that occurs in only part of the embryo shown in Fig. 4B . We conclude that phosphorylation of Smad proteins is impaired in dCBP mutant embryos.
At later stages of development, when embryos are in the beginning of the germband elongation phase, phosphory-lated Smad protein continues to accumulate in dorsal cells in the wild-type (Fig. 4C) . Interestingly, Dpp/Screw signaling recovers in dCBP mutant embryos at this stage, as revealed by the anti-phospho Smad antibody (Fig. 4D) . We considered the possibility that phospho-Smad staining in dCBP mutant embryos is caused by the paternal contribution of dCBP at this later stage of development. To distinguish between hemizygous and heterozygous embryos, males carrying a ftz-lacZ transgene on the FM7c balancer chromosome were crossed to females containing dCBP germline clones, and the resulting embryos were doublestained for lacZ mRNA and phospho-Smad protein. No difference between embryos that lack or contain lacZ mRNA was observed (data not shown), indicating that phospho-Smad staining recovers in the absence of zygotically produced dCBP. In summary, dCBP inhibits signaling by Dpp/Screw in early embryos by preventing expression of the Tolloid protease and Screw itself, whereas in older embryos, Dpp is able to signal but unable to activate downstream target genes such as rhomboid.
Cells receiving the dpp signal require dCBP for target gene expression
Since not every embryo derived from nej 1 germline clones produces a mutant phenotype, we investigated whether in the same embryo, Dpp/Screw is able to signal but unable to turn on gene expression. Embryos were double stained with a rhomboid probe and the anti-phospho Smad antibody. For clarity, the expression pattern of rhomboid in wild-type and mutant embryos is shown in Fig. 5A and B, respectively. The rhomboid pattern consists of two lateral stripes that are activated by Dorsal and repressed by the Snail protein in ventral cells (Ip et al., 1992) . In dorsal parts, rhomboid is independently regulated by Dpp/Screw signal- (A, B) Hybridization of a rhomboid (rho) antisense probe to cellularized embryos shown in a ventrolateral view. In wild-type (wt) embryos (A), the pattern consists of two lateral stripes expressed in response to the Dorsal protein, and expression in the dorsal ectoderm in response to Dpp/Screw signaling. In the CBP mutant derived from nej 1 germline clones (B), the lateral stripes are expressed normally, whereas the dorsal staining is eliminated. (C, D) Gastrulating embryos double-stained with a rho RNA probe and anti-phospho Smad antibodies. Anterior is to the left and dorsal up. In the wt embryo shown in (C), the dorsal rho expression partially overlaps with the phospho-Smad staining, consistent with a requirement for Dpp/Screw signaling to activate the ectodermal rho expression. However, the phospho-Smad staining extends further toward the poles than does the rho pattern. It is likely that spatially localized transcription factors cooperate with Smad proteins to activate dorsal rho expression. Rho staining is also observed in the neuroectoderm, but is weaker at this stage is weaker than in the embryos shown in (A) and (B). In most CBP germline clone embryos, neither phosphorylated Smad proteins nor dorsal rho expression is observed (data not shown). However, in the CBP mutant embryo shown in (D), dorsal rho staining is not observed, although the cells contain phosphorylated Smad proteins. This suggests that CBP is required downstream of Smad phosphorylation for dorsal rho expression. By contrast, rho expression in the neuroectoderm is unaffected by the CBP mutation. ing (Ashe et al., 2000) . As shown in Fig. 5B , the dorsal, Dpp/Screw-dependent, rhomboid staining is lost in dCBP mutants, whereas expression of the two lateral stripes is unaffected. When wild-type embryos are stained with the anti-phospho Smad antibody in addition to the rhomboid probe, the two patterns overlap in dorsal regions, although the anti-phospo Smad staining extends further toward the poles than does rhomboid expression (Fig. 5C ). Most dCBP mutant embryos lack phosphorylated Smad proteins, and consequently do not express rhomboid in dorsal cells (data not shown). However, in a few late-stage dCBP mutant embryos, phosphorylated Smad proteins are present in dorsal cells, but still no dorsal rhomboid expression is observed, although the two lateral rhomboid stripes are expressed at normal levels (Fig. 5D ). dCBP can therefore act downstream of Smad phosphorylation to regulate Dpp/ Screw-target genes, presumably via direct interactions with the Drosophila Smad protein Mad.
Two other dCBP alleles similarly influence the Dpp/Screw pathway
Since the amount of dCBP is only slightly reduced in embryos derived from nej 1 germline clones as compared with wild-type (Fig. 1) , other means of lowering the dose of dCBP may also affect the Dpp/Screw pathway. We used two stronger alleles of dCBP, nej 3 that is believed to be a null allele (Akimaru et al., 1997a) , and nej Q7 that is considered an antimorph (Florence and McGinnis, 1998) . Although germline clones cannot be generated with these alleles, embryos collected from the stocks contain only half the amount of maternal dCBP. We hybridized these embryos with probes from the tolloid and rhomboid genes, which shows that similar phenotypes to those observed in germline clone embryos from the nej 1 allele can be found (Fig. 6) . Tolloid expression is restricted to an anterior cap and to weak posterior staining in nej 3 (Fig. 6B ) and nej
Q7
( Fig. 6C ) embryos, compared with staining throughout the dorsal part of the anteroposterior axis in wild-type embryos (Fig. 6A ). Both nej 3 (Fig. 6E ) and nej Q7 (Fig. 6F ) embryos lack the dorsal rhomboid pattern that wild-type embryos express in response to Dpp/Screw signaling (Fig. 6D) . Although the phenotype is weaker in nej 3 and nej Q7 embryos than in nej 1 germline clone embryos, these results are consistent with our conclusion that genes in the Dpp/Screw pathway are sensitive to a small decline in dCBP levels.
Discussion
Our results suggest that several transcription factors that regulate expression of Dpp/Screw signaling components require the dCBP coactivator for their function in Drosophila embryos, and implicate dCBP in regulation of the Dpp/ Screw pathway independently of an interaction with Smad proteins (summarized in Fig. 7 ). An additional role of dCBP is to regulate Dpp-target genes, acting at a step downstream of Smad protein phosphorylation. It is likely that direct interactions between dCBP and Mad/Medea contribute to regulation of Dpp target genes (Fig. 7) . Such interactions have been observed in vitro, both in mammalian systems and using Drosophila proteins (Feng et al., 1998; Janknecht et al., 1998; Nishihara et al., 1998; Pouponnot et al., 1998; Topper et al., 1998; Waltzer and Bienz, 1999 ). However, a major cause of impaired Dpp/Screw signaling in dCBP mutant embryos is due to reduced tolloid expression. This prevents Dpp/Screw from initiating a signaling event in cells that would normally receive the Dpp/Screw signal (Fig. 4B) , presumably by a failure to cleave the Dpp-Sog Fig. 7 . Summary of the requirements for dCBP in Dpp/Screw signaling. A cell is depicted as a expressing the screw (scw), tolloid (tld), and twistedgastrulation (tsg) genes on the top. dCBP is recruited to the tolloid enhancer as well as to the tsg and screw genes through interactions with unidentified factors (proteins X, Y, and Z). Scw, Tld, and Tsg proteins are secreted from the cell, where Tsg forms a complex with the Sog inhibitor that can be proteolytically cleaved by Tld. This allows the Dpp and Scw proteins to bind to their receptors, which leads to phosphorylation of Smad proteins in the receiving cell (bottom). The phosphorylated Smad protein Mad dimerizes with its partner Medea, and translocates to nucleus, where it turns on gene expression. dCBP is required downstream of Smad protein phosphorylation, presumably acting as a Mad coactivator on the rhomboid dorsal ectoderm enhancer. and/or Screw-Sog complexes. In fact, a majority of embryos that do not express the Dpp/Screw-target gene rhomboid in dorsal cells, also do not contain phosphorylated Smad proteins (data not shown). Furthermore, the pattern of phosphorylated Smad proteins correlates closely to that of tolloid expression (compare Figs. 3 and 4) . For example, in many early, cellularizing dCBP mutant embryos, an anterior patch of both tolloid expression and phosphorylated Smad staining remains (Figs. 3B and 4B) . At later stages, tolloid expression recovers in dCBP mutant embryos, as does Dpp/ Screw signaling as revealed by Smad protein phosphorylation (Figs. 3D and 4D ). This recovery of tolloid expression at later stages of development might explain the recovery of phosphorylated Smad proteins in dCBP mutant embryos, by allowing Dpp/Screw to signal. For these reasons, regulation of tolloid expression appears to be a major means of controlling Dpp/Screw signaling by dCBP.
It is likely that reduced screw expression also contributes to the reduction of phosphorylated Smad proteins observed in dCBP mutant embryos. In both screw and tolloid mutants, phosphorylation of Mad is eliminated (Dorfman and Shilo, 2001 ) and dorsal rhomboid expression is abolished (Marques et al., 1997; Nguyen et al., 1998) . Furthermore, progressive reduction in Screw activity leads to a corresponding progressive deletion of dorsal-most cell fate, the amnioserosa (Arora et al., 1994) .
Tsg is required together with Sog to generate peak Dpp activity in dorsal midline cells. Reduced tsg expression in dCBP mutants may therefore contribute to the lack of Dpp/ Screw-target gene expression. However, we do not believe that it can explain the defects in dCBP mutants, because in tsg mutants, low levels of Dpp signaling persist in a broad dorsal domain, leading to expanded rhomboid expression in dorsal cells (Ross et al., 2001) . By contrast, in dCBP mutant embryos, expression of genes in response to a low threshold of Dpp activity, such as U-shaped and the dorsal rhomboid pattern, is eliminated (Ashe et al., 2000; see also Fig. 5) .
Our experiments do not address whether dCBP regulation of tolloid, screw, and tsg expression is direct or indirect. However, since expression of these genes begins at about the time when zygotic transcription initiates in the embryo, and the effect of dCBP is evident from the onset of expression of tolloid and screw, we favor the notion that dCBP is acting directly on the enhancers of these genes. It is not yet understood whether HATs such as CBP primarily act to acetylate large chromosomal domains, or are directed to specific genes (Roth et al., 2001 ). In the case of the tolloid gene, our results indicate that dCBP is being recruited to the enhancer by a DNA-binding protein, since the isolated enhancer removed from its normal chromosomal location requires dCBP for its activity.
Given its central position in gene regulation and the great number of mammalian transcription factors shown to interact with CBP, relatively few genes are affected by the dCBP mutation. For example, activation and repression mediated by the Dorsal protein are unaffected in the dCBP mutant embryos, as demonstrated by the expression patterns of Dorsal target genes (Figs. 2 and 5; and data not shown). Also, no defects in early segmentation gene expression could be observed in germline clone mutants (data not shown). However, the nej 1 mutation used in this study to create dCBP mutant germline clone embryos is a weak mutation that results in a very modest reduction in dCBP levels (Fig. 1) . Since other means of reducing the dCBP amount by approximately two-fold results in similar gene expression defects (Fig. 6) , Smad proteins and the unidentified activators of tolloid, tsg, and screw expression are particularly sensitive to a decline in dCBP concentration. It may not be a coincidence that screw, tsg, tolloid, and Dpptarget gene expression are all specifically affected by a small dCBP reduction. Perhaps components of the Dpp/ Screw signal transduction pathway have evolved to be coordinately regulated by a common coactivator. Given the phylogenetic conservation of the CBP protein and the TGF-␤ signal transduction pathway, as well as the ability of CBP and Smad proteins to interact in vitro, CBP is likely to play an equally important role in TGF-␤ signaling in other metazoans.
